1OWild-type KRAS mediates growth inhibition and resistance to MEK inhibitors through dimerization with mutant KRAS in lung adenocarcinoma

C. Ambrogio,J. Köhler,Zhiwei Zhou,Haifeng Wang,Raymond M. Paranal,M. Capelletti,C. Caffarra,S. Li,Qi Lv,David Santamaría,K. Westover,P. Jänne

Published 2017 in Annals of Oncology

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2017
Venue
Annals of Oncology
Publication date
2017-09-01
Fields of study
Biology, Medicine
Identifiers
DOI 10.1093/ANNONC/MDX361
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

α4-α5 Helices on Surface of KRAS Can Accommodate Small Compounds That Increase KRAS Signaling While Inducing CRC Cell Death
2023cites this paper
Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
2022cites this paper
Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women
2018cites this paper